Uterine sarcomas: A 10-year experience and a review of the literature

Women's Oncology Review

Volumn 4, Issue 1, 2004, Pages 7-12

  Yildirim, Yusuf ^a   Inal, M Murat ^a   Sanci, Muzaffer ^a   Şentaş, Abdulmuttalip ^a   Hanhan, Merih ^a  

^a Aegean Maternity Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; PACLITAXEL; TAMOXIFEN; VINCRISTINE;

ADULT; AGE; AGED; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHI SQUARE TEST; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM SARCOMA; EXPERIENCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT NEURILEMOMA; MEDICAL LITERATURE; MEDICAL RECORD; METASTASIS; MIXED MULLERIAN TUMOR; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; REVIEW; SALPINGOOOPHORECTOMY; SURVIVAL RATE; SURVIVAL TIME; TURKEY (REPUBLIC); UTERUS SARCOMA;

EID: 2542554193     PISSN: 14733404     EISSN: None     Source Type: Journal    
DOI: 10.1080/14733400410001669894     Document Type: Review

References (39)

1. Bosquet EG, Martinez-Polones JM, Bosquet JG, et al. Uterine sarcoma: a clinicopathological study of 93 cases. Eur J Gynaecol Oncol 1997;18:192-5
2. Ayhan A, Tuncer ZS, Tanir M, et al. Uterine sarcoma: the Hacettepe hospital experience of 88 consecutive patients. Eur J Gynaecol Oncol 1997;18:146-8
3. Piuna B, Rabinovich L, Yanai -Inbar I, et al. Uterine sarcoma in the South of Israel: study of 36 cases. J Surg Oncol 1997;64:55-62
4. Lewis JL Jr, Berchuck A, Rubin SC, et al. Uterine sarcomas. In Shiu MH, Brennan M, eds. Surgical Management of Soft Tissue Sarcoma. Philadelphia: Lea & Febiger, 1989:213
5. Deniaud-Alexandre E, Chauvenic L, della Rochefordiere A, et al. Role of adjuvant therapy in uterine sarcoma: experience of Curie Institute. Cancer Radiother 2001;5:743-9
6. Kahanpaa K, Wahlstrom T, Grohn P, et al. Sarcomas of the uterus: a clinocopathologic study of 119 patients. Obstet Gynecol 1986;67:417-24
7. Disaia PJ, Creasman WT. Sarcoma of the uterus. In Disaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. St Louis: Mosby Year Book, Inc., 1993:194
8. Marchese MJ, Liskow AJ, Crum CP, et al. Uterine sarcoma: a clinicopathologic study, 1965-1981. Gynecol Oncol 1984;18:299-312
9. Peters WA, Kumar NB, Fleming WP, Morley GW. Prognostic features of sarcomas and mixed tumors of the endometrium. Obstet Gynecol 1984;63:550-6
10. Goff BA, Rice LW, Fleischhacker D, et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 1993;50:105-9
11. Schwartz Z, Dgani R, Lancet M, Kessler I. Uterine sarcoma in Israel: a study of 104 cases. Gynecol Oncol 1985;20:354-63
12. Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994;83:414-8
13. Clement PB, Oliva E, Young RH. Müllerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen associated endometrial lesions. Eur J Gynecol Pathol 1996;15:222-9
14. Sabatini R, DiFazio F, Loizzi P. Uterine leiomyosarcoma in a postmenopausal woman treated with tamoxifen: case report. Eur J Gynaecol Oncol 1999;20:317-8
15. Seoud MAF, Johnson J, Weed JC. Gynecologic tumors in tamoxifen-treated woman with breast cancer. Obstet Gynecol 1993;82:165-9
16. Kloos I, Delaloge S, Pautier P, et al. Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature. Int J Gynecol Cancer 2002;12:496-500
17. Ismail SM. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994;47:827-33
18. Mc Cluggage WG, Aldulkader M, Price JH, et al. Uterine carcinosarcomas in patients-receiving tamoxifen. A report of 19 cases. Int J Gynecol Cancer 2000;10: 280-4
19. Stearns V, Gelmann EP. Does tamoxifen cause cancer in humans? J Clin Oncol 1998;16:779-92
20. White IN. The tamoxifen dilemma. Carcinogenesis 1999;20:1153-60
21. Chen SS. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus. Gynecol Oncol 1989;32:215-17
22. Liao Q, Wang J, Han J. Clinical and pathological analysis on 106 cases with uterine sarcoma. Zhonghua Fu Chan Za Zhi 2001;36:104-7
23. Major FJ, Blessing JA, Siverberg SG, et al. Prognostic factors in early stage uterine sarcoma. A Gynecologic Oncology Group Study. Cancer 1993;71: 1702-9
24. Tinkler SD, Cowie VJ. Uteine sarcomas: a review of the Edinburgh experience from 1974 to 1992. Brit J Radiol 1993;66:998-1001
25. Altaras MM, Jaffe R, Cohen I, et al. Role of prolonged excessive estrogen stimulation in the pathogenessis of endometrial sarcomas: two cases and a review of the literature. Gynecol Oncol 1990;38:273-7
26. Wade K, Quinn MA, Hammond I, et al. Uterine sarcoma: steroid receptors and response to hormonal therapy. Gynecol Oncol 1990;39:364-7
27. Olah KS, Gee H, Blunt S, et al. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 1991;27: 1095-9
28. Mantravadi RVP, Bardawill WA, Lochman DJ, et al. Uterine sarcomas: an analysis of 69 patients. In J Radiat Oncol Biol Phys 1981;7:917-22
29. Larson B, Silfversward C, Nilsson B, Petterson F. Prognostic factors in uterine leiomyosarcoma: a clinical and histopathological study of 143 cases: the radium-hemmet series 1936-1981. Acta Oncol 1990;29:185-91
30. Bokhman JV, Yakovlera IA, Urmanchejera AF. Treatment of patients with sarcoma of the uterus. Eur J Gynaecol Oncol 1990;11:225-31
31. Gadducci A, Romanini A. Adjuvant chemotherapy in early stage uterine sarcomas: an open question. Eur J Gynaecol Oncol 2001;22:352-7
32. Bai P, Zhang W, Sun J. Combination chemotherapy of uterine sarcomas. Zhonghua Zhong Liu Za Zhi 2000;22: 80-2
33. Pautier P, Genestie C, Fizazi K, et al. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas. Int J Gynecol Cancer 2002;12:749-54
34. Chauveinc L, Deniaud E, Plancher C, et al. Uterine sarcoma: the Curie Institute experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 1999;72:232-7
35. Gadducci A, Sartori E, Landoni F, et al. The prognostic relevance of histological type in uterine sarcoma: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol 2002;23:295-9
36. El Husseiny G, Al Bareedy N, Mourad WA, et al. Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 2002;25:256-60
37. Soumarova R, Horova H, Seneklova Z, et al. Treatment of uterine sarcoma. A survey of 49 patients. Arch Gynecol Obstet 2002;266:92-5
38. Hsieh Ch, Lin H, Huang CC, et al. Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases. Acta Obstet Gynecol Scand 20003;82:74-81
39. Bodner K, Bodner-Adler B, Kimberger O, et al. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study. J Reprod Med 2003; 48:95-100